Projects per year
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
Mathôt R.A.A.: Population pharmacokinetic-pharmacodynamic research
Achterbergh, R., Berends, S., ten Berg - Lammers, L., Bijleveld, Y., Hodiamont, C., Preijers, T., Wind, C., Mathot, R., Fijnvandraat, K., de Haan, T., Kemper, M., Klümpen, H., van Hest, R., Kuks, P., Zwaan, C. M., Franken, L., Hazendonk, C., Masman, A., van Moort, I., Sassen, S., Schutte, L. M., Cnossen, M., van Gelder, T., Kruip, M. J. H. A., Leebeek, F. W. G. & Tibboel, D.
1/12/2012 → …
Project: Research
-
Cabozantinib in patients with advanced and progressing hepatocellular carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A-L., el-Khoueiry, A. B., Rimassa, L., Ryoo, B-Y., Cicin, I., Merle, P., Chen, Y., Park, J-W., Blanc, J-F., Bolondi, L., Klümpen, H-J., Chan, S. L., Zagonel, V., Pressiani, T., Ryu, M-H., Venook, A. P., Hessel, C., Borgman-Hagey, A. E., & 2 others , 2018, In: New England journal of medicine. 379, 1, p. 54-63Research output: Contribution to journal › Article › Academic › peer-review
1549 Citations (Scopus) -
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)
Hendriks, P., Rietbergen, D. D. D., van Erkel, A. R., Coenraad, M. J., Arntz, M. J., Bennink, R. J., Braat, A. E., Crobach, S., van Delden, O. M., Dibbets-Schneider, P., van der Hulle, T., Klümpen, H-J., van der Meer, R. W., Nijsen, J. F. W., van Rijswijk, C. S. P., Roosen, J., Ruijter, B. N., Smit, F., Stam, M. K., Takkenberg, R. B., & 4 others , 2024, (E-pub ahead of print) In: European journal of nuclear medicine and molecular imaging.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Franssen, S., Holster, J. J., Jolissaint, J. S., Nooijen, L. E., Cercek, A., D'Angelica, M. I., Homs, M. Y. V., Wei, A. C., Balachandran, V. P., Drebin, J. A., Harding, J. J., Kemeny, N. E., Kingham, T. P., Klümpen, H-J., Mostert, B., Swijnenburg, R-J., Soares, K. C., Jarnagin, W. R. & Groot Koerkamp, B., 1 Feb 2024, In: Annals of surgical oncology. 31, 2, p. 1296-1297 2 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Franssen, S., Holster, J. J., Jolissaint, J. S., Nooijen, L. E., Cercek, A., D’Angelica, M. I., Homs, M. Y. V., Wei, A. C., Balachandran, V. P., Drebin, J. A., Harding, J. J., Kemeny, N. E., Kingham, T. P., Klümpen, H-J., Mostert, B., Swijnenburg, R-J., Soares, K. C., Jarnagin, W. R. & Groot Koerkamp, B., Jan 2024, In: Annals of surgical oncology. 31, 1, p. 115-124 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
Blay, J-Y., Casali, P., Ray-Coquard, I., Seckl, M. J., Gietema, J., de Herder, W. W., Caplin, M., Klümpen, H-J., Glehen, O., Wyrwicz, L., Peeters, R., Licitra, L., Girard, N., Piperno-Neumann, S., Kapiteijn, E., Idbaih, A., Franceschi, E., Trama, A., Frezza, A-M., Hohenberger, P., & 8 others , 1 Apr 2024, In: The Lancet Regional Health - Europe. 39, 100861.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access
Datasets
-
Supplementary Material for: Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
Labeur, T. A. (Creator), Takkenberg, R. B. (Creator), Ijzermans, J. N. M. (Contributor), Eskens, F. A. L. M. (Contributor), Klümpen, H. (Creator), Takkenberg, R. B. (Creator) & Klümpen, H. (Creator), Karger Publishers, 2018
DOI: 10.6084/m9.figshare.7291280, https://karger.figshare.com/articles/Supplementary_Material_for_Body_Composition_Is_an_Independent_Predictor_of_Outcome_in_Patients_with_Hepatocellular_Carcinoma_Treated_with_Sorafenib/7291280
Dataset
-
Supplementary Material for: Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?
Merola, E. (Creator), Zandee, W. (Creator), Klümpen, H. (Creator), Makulik, K. (Creator), Geboes, K. (Creator), Couvelard, A. (Creator), Cros, J. (Creator), Hoorens, A. (Creator), Stephenson, T. (Creator), Zajȩcki, W. (Contributor), Munir, A. (Creator), Klümpen, H. (Creator) & DeHerder, W. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.12213119.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Histopathological_Revision_for_Gastroenteropancreatic_Neuroendocrine_Neoplasms_in_Expert_Centers_Does_It_Make_the_Difference_/12213119/1
Dataset
-
Supplementary Material for: Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference?
Merola, E. (Creator), Zandee, W. (Creator), Klümpen, H. (Creator), Makulik, K. (Creator), Geboes, K. (Creator), Couvelard, A. (Creator), Cros, J. (Creator), Hoorens, A. (Creator), Stephenson, T. (Creator), Zajȩcki, W. (Contributor), Munir, A. (Creator), Klümpen, H. (Creator) & DeHerder, W. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.12213119, https://karger.figshare.com/articles/Supplementary_Material_for_Histopathological_Revision_for_Gastroenteropancreatic_Neuroendocrine_Neoplasms_in_Expert_Centers_Does_It_Make_the_Difference_/12213119
Dataset
-
Supplementary Material for: Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
Labeur, T. A. (Creator), Takkenberg, R. B. (Creator), Ijzermans, J. N. M. (Contributor), Eskens, F. A. L. M. (Contributor), Klümpen, H. (Creator), Takkenberg, R. B. (Creator) & Klümpen, H. (Creator), Karger Publishers, 2018
DOI: 10.6084/m9.figshare.7291280.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Body_Composition_Is_an_Independent_Predictor_of_Outcome_in_Patients_with_Hepatocellular_Carcinoma_Treated_with_Sorafenib/7291280/1
Dataset